Liven Pharma Limited (PSX:LIVEN)
Pakistan · Delayed Price · Currency is PKR 34.80
-0.07 (-0.20%)
At close: Aug 20, 2026
Liven Pharma Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -701.22 | -584.46 | 41.74 | -12.33 | -14.29 | -14.63 |
Depreciation & Amortization | 29.42 | 27.17 | 24.87 | 13.1 | 14.56 | 16.08 |
Other Amortization | 328.27 | 328.27 | 0.69 | - | - | - |
Provision & Write-off of Bad Debts | 126.44 | 116.87 | - | - | - | - |
Other Operating Activities | 120.8 | 92.58 | 1.15 | -2.9 | -3.22 | -3.55 |
Change in Accounts Receivable | 106.38 | -21.52 | -42.29 | - | - | - |
Change in Inventory | 122.74 | 0.46 | -11.82 | - | - | - |
Change in Accounts Payable | 17.89 | 39.43 | 0.21 | - | -0.07 | -4.16 |
Change in Other Net Operating Assets | -9.33 | -0.52 | -0.75 | -0.14 | 0.76 | -0.52 |
Operating Cash Flow | 216.89 | -1.72 | 13.8 | -2.27 | -2.26 | -6.79 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | -32.16 | -22.84 | - | - | - | - |
Sale (Purchase) of Intangibles | -12.76 | -10 | - | - | - | - |
Investing Cash Flow | -237.45 | -32.84 | - | - | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Short-Term Debt Issued | - | 168.72 | 11.34 | 2.27 | 2.24 | 6.79 |
Long-Term Debt Issued | - | 6.68 | 1.36 | - | - | - |
Total Debt Issued | -0.02 | 175.4 | 12.7 | 2.27 | 2.24 | 6.79 |
Short-Term Debt Repaid | - | -156.14 | - | - | - | - |
Long-Term Debt Repaid | - | -1.8 | -3.54 | - | - | - |
Total Debt Repaid | -8.31 | -157.94 | -3.54 | - | - | - |
Net Debt Issued (Repaid) | -8.34 | 17.46 | 9.16 | 2.27 | 2.24 | 6.79 |
Financing Cash Flow | 191.66 | 17.46 | 9.16 | 2.27 | 2.24 | 6.79 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Miscellaneous Cash Flow Adjustments | -17.32 | 0.03 | - | - | - | - |
Net Cash Flow | 153.79 | -17.07 | 22.96 | 0 | -0.02 | -0.01 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 184.72 | -24.56 | 13.8 | -2.27 | -2.26 | -6.79 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 186.39% | -19.30% | 5.63% | - | - | - |
Free Cash Flow Per Share | 2.05 | -0.35 | 345.08 | -0.19 | -0.19 | -0.56 |
Levered Free Cash Flow | 152.36 | 151.56 | -163.82 | 3.45 | 4.31 | 0.03 |
Unlevered Free Cash Flow | 153.78 | 152.02 | -163.81 | 3.45 | 4.31 | 0.03 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash Interest Paid | 2.31 | 0.47 | 0.1 | - | - | - |
Change in Working Capital | 237.68 | 17.84 | -54.65 | -0.14 | 0.7 | -4.69 |